Background
==========

During development, the mammary gland undergoes well-orchestrated, hormone-dependent morphological changes to become a milk-producing machine during pregnancy and lactation, which subsequently regresses to a quiescent organ by involution.[@R1]^,^[@R2] In early gestation, mammary epithelial cells (MECs) proliferate, whereas in late pregnancy and lactation, they differentiate for milk production. During involution, most secretory alveolar MECs undergo programmed cell death (PCD); remaining cells are remodeled into pre-pregnancy-like glandular structures, in a process consisting of two phases and completed within 10 d in mice.[@R3] The first involution phase, lasting 48 h post-weaning, is regulated by local factors[@R4]^,^[@R5] and is reversible, i.e., if pups are returned to mother, MEC death is halted and lactation resumes; the second phase is regulated by circulating hormones,[@R3] is characterized by extensive tissue remodeling that is dependent on matrix metalloproteinases (MMPs),[@R6] and is irreversible.

Within the first 72 h, residual milk and dead cells are primarily cleared from alveolar lumens by neighboring, living MECs in a highly conserved process resembling phagocytosis and uniquely termed efferocytosis (from the greek word 'effero', to carry to the grave).[@R7]^,^[@R8] Professional phagocytes, such as macrophages, also infiltrate the gland, mostly after the third day of involution,[@R8] and play a critical role in stroma remodeling,[@R9] concomitantly creating a tumor-promoting microenvironment[@R10]^,^[@R11] that potentially contributes to the poor prognosis of pregnancy-associated breast cancer (PABC).[@R12]

Leukemia inhibitory factor (LIF),[@R13]^,^[@R14] death receptor ligands[@R10]^,^[@R15] and transforming growth factor β 3 (TGFB3)[@R16] are strongly upregulated during the first 12 h of involution, and the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, induced by LIF-dependent STAT3 phosphorylation, is critical for apoptosis initiation and timely gland involution.[@R13]^,^[@R14]^,^[@R17]^,^[@R18] CD14 is also upregulated during involution and exposed on MECs in a STAT3-dependent manner.[@R10]^,^[@R19] Although PCD during mammary involution has been primarily attributed to apoptosis, a recent study showed that cell death during the first phase of involution is mediated by permeabilization of lysosomal membranes.[@R20] It is, thus, important to note that the term "apoptosis" as used here also includes this newly described lysosome-mediated cell death.

Studies on bovine mammary glands have demonstrated that, in parallel to apoptosis, the self-catabolic process of autophagy[@R21] is also activated during involution.[@R22]^,^[@R23] In vitro, apoptosis and autophagy induction in bovine MECs is accompanied by TGFB1 and TGFBR2 upregulation,[@R23] resulting in increased insulin growth factor-binding protein (IGFBP) levels and decreased AKT phosphorylation.[@R24] Autophagy regulation in MECs is even more complex, as EGF also suppresses autophagy via MTOR activation, whereas 17β-estradiol and progesterone stimulate autophagy by suppressing MTOR.[@R25]

Despite evidence for autophagy induction during involution, its specific role during this important developmental process remains unclear. If autophagy is activated as a cell-survival mechanism in response to apoptosis-inducing signals triggered by cessation of lactation,[@R26] autophagy defects may accelerate MEC apoptosis and gland remodeling; alternatively, autophagy may act as a cell death mechanism complementary to apoptosis[@R22] and, thus, its impairment may decrease MEC death and delay involution; the autophagic machinery may also participate in dead cell removal.[@R27] To date, there is no genetic evidence supporting a particular functional role for autophagy in mammary involution over another.

Using the *Gfp-Lc3* mice,[@R28] ubiquitously expressing a fluorescent GFP-fusion of the essential [a]{.ul}u[t]{.ul}opha[g]{.ul}y-related (ATG) protein LC3 (ortholog of ATG8), we determined that autophagy is induced early in involution. Monoallelic *Becn1* loss or MEC-specific *Atg7* deletion compromised autophagosome formation, but did not affect apoptosis during the first 48 h post-weaning; however, the second involution phase was prolonged in association with delayed alveolar collapse, dead cell accumulation in alveolar lumens and slower gland repopulation by adipocytes. *Atg*-defective mammary tissues exhibited persistent involution-associated macrophage infiltration, which possibly creates a tumor-modulating microenvironment, and developed ductal ectasia, that is indicative of long-term impairment in mammary remodeling. Our studies genetically confirm the critical role of MECs in dead cell clearance during involution and expand the accumulating evidence on the importance of ATG proteins in phagocytosis,[@R29] innate immune response[@R30]^,^[@R31] and efferocytosis[@R32]^,^[@R33] by demonstrating that, in addition to the previously reported endocytic processing defect,[@R29]^,^[@R32]^,^[@R34] impairment of autophagic machinery proteins compromises efferocytosis in vivo at the early step of engulfment.

Results
=======

*Atg*-dependent autophagy induction in early mammary involution
---------------------------------------------------------------

The functional status of autophagy at different stages of mammary gland development was investigated in the *Gfp-Lc3* mice,[@R28] ubiquitously expressing the ATG protein LC3 (ATG8) fused to GFP ([Fig. 1A](#F1){ref-type="fig"}). The diffuse cytoplasmic LC3 distribution observed in virgin and lactating mammary glands changed to a perinuαclear punctate pattern, indicative of LC3 lipidation and translocation to the autophagosome membrane, within hours of forced pup-weaning, demonstrating autophagy induction very early in involution. Autophagosome formation peaked at 24 h post-weaning and returned to baseline after 72 h. Mammary gland *Becn1* mRNA was induced during lactation and peaked at 24 h post-weaning, whereas *Atg7* and *Map1lc3α* (*Lc3*) mRNA levels were induced only during involution ([Fig. 1B](#F1){ref-type="fig"}).

![**Figure 1.** Autophagy is induced in the early phase of mammary involution. (**A**) GFP fluorescence on frozen sections of mammary glands from *GFP-LC3* mice. (**B**) RT-PCR quantification of *Becn1*, *Atg7* and *Map1lc3α* mRNA in mammary glands from wild-type mice. L (Lact), lactation; I (Inv), involution; d, days; h, hours.](auto-9-459-g1){#F1}

Allelic *Becn1* loss or MEC-specific *Atg7* deletion compromised involution-induced autophagy ([Fig. 2A and B](#F2){ref-type="fig"}, and [Fig. 2D--F](#F2){ref-type="fig"}, respectively) and was accompanied by severely blunted changes in *Becn1* and *Lc3* mRNA ([Fig. 2C and G](#F2){ref-type="fig"}), thus indicating that upregulation of autophagy in the early phase of mammary involution is both *Becn1*- and *Atg7*-dependent, and defects in either ATG protein decrease postlactational autophagy induction. In contrast to the ubiquitous (in all cell types and tissues) monoallelic *Becn1* deletion in *Becn1^+/−^* mice, in the mammary gland-specific *Atg7*-deficient mouse model described here, *Atg7* was deleted only in secretory MECs after pregnancy and lactation,[@R35]^,^[@R36] thus indicating that alveolar epithelial cells are primarily responsible for the autophagic response observed shortly after pup weaning. It is also of interest that both allelic *Becn1* loss and MEC-specific *Atg7* deletion compromised involution-associated LC3 upregulation, thus suggesting that LC3 induction is dependent on and/or coregulated with BECN1 and ATG7 expression. To our knowledge, this finding has not been reported before and is definitely worthy of further investigation.

![**Figure 2.** Monoallelic *Becn1* loss or MEC-specific *Atg7* deletion compromises autophagy induction in mammary involution. (**A**) EM micrographs of *Becn1^+/+^* and *Becn1^+/−^* mammary glands on day 2 post-weaning. Red arrows point to autophagosomes. (**B**) Quantification of autophagosomes in *Becn1^+/+^* and *Becn1^+/−^* mammary glands on day 2 post-weaning by EM. (**C**) RT-PCR quantification of *Becn1* and *Map1lc3α* mRNA in mammary glands from *Becn1^+/−^* mice. (**D--F**) ATG7, LC3 and SQSTM1 IHC respectively on mammary glands from parous wild-type and *Atg7*^F/F^;WAP-*Cre* mice on day 2 post-weaning. (**G**) RT-PCR quantification of *Becn1* and *Map1lc3α* mRNA in mammary glands from parous wild-type and *Atg7*^F/F^;WAP-*Cre* mice type. L, lactation; I, involution; d, days; h, hours. Parous mice: after second pregnancy and lactation](auto-9-459-g2){#F2}

*Atg* defects delay mammary involution in association with dead cell accumulation in alveolar lumens
----------------------------------------------------------------------------------------------------

To investigate how *Atg* defects impact mammary involution, we examined wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mammary glands at successive involution time points ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Transient involution delays, most apparent between days 3 and 5 post-weaning, were observed in both *Atg*-deficient genetic backgrounds. Involuting gland morphology appeared grossly unaffected by autophagy functional status within the first 48 h. However, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mammary glands demonstrated abnormally distended milk- and dead cell-filled alveoli for at least 72 and 96 h post-weaning, respectively ([Fig. 3](#F3){ref-type="fig"}) and an accompanying delay in stroma remodeling ([Fig. 4](#F4){ref-type="fig"}). *Becn1^+/−^* and MEC-specific *Atg7*-deficient glands were repopulated by adipocytes to wild-type levels after 5 and 10 d, respectively ([Fig. 4](#F4){ref-type="fig"}), indicating that MEC-specific *Atg7* deficiency resulted in longer, though still temporary, gland remodeling delay than ubiquitous monoallelic *Becn1* loss.

![**Figure 3.** Monoallelic *Becn1* loss or MEC-specific *Atg7* deletion delays mammary involution. H&E-stained sections of formalin-fixed and paraffin-embedded mammary tissues from parous wild-type, *Becn1^+/−^* and *Atg7*^F/F^;WAP-*Cre* mice on days 1--7 post-weaning. Parous mice: after second pregnancy and lactation.](auto-9-459-g3){#F3}

![**Figure 4.** Monoallelic *Becn1* loss or MEC-specific *Atg7* deletion delays mammary involution. (**A**) Whole mammary gland mounts from parous wild-type, *Becn1*^+/−^ and *Atg7*^F/F^;WAP-*Cre* mice on days 1--4 post-weaning. (**B**) Mammary gland repopulation by adipocytes (adipose tissue/total mammary tissue, %) during days 0.5--14 post-weaning.](auto-9-459-g4){#F4}

To gain insight into the mechanism(s) by which defects in autophagic machinery proteins delay involution, MEC apoptosis was quantified ([Fig. 5A, B, D and E](#F5){ref-type="fig"}). During the first 72 h post-weaning, MECs exhibited high apoptotic rates, independent of autophagic responsiveness ([Fig. 5B and E](#F5){ref-type="fig"}). Although autophagy is regularly induced as a cytoprotective mechanism under stress,[@R37]^-^[@R40] the observation that autophagy-defective MECs were not more susceptible than their wild-type counterparts to post-lactational cell death was not surprising, given that the prosurvival effects of autophagy become readily apparent only in an apoptosis-defective background.[@R37]^-^[@R40] Quantification of apoptotic body (AB) clearance by neighboring, still living, MECs revealed that *Atg*-deficient MECs exhibited decreased engulfment compared with wild-type MECs after the first 24 h post-weaning, i.e., after the peak of autophagosome formation ([Fig. 5C and F](#F5){ref-type="fig"}). Furthermore, engulfment difference between wild-type and *Atg*-deficient MECs continually increased between 48 and 96 h, remaining high at least until involution day 5 and probably accounting for the persistently high AB numbers in *Becn1^+/−^* and MEC-specific *Atg7*-deficient mammary glands beyond 72 h; abnormal intraluminal dead cell accumulation ([Fig. 5G](#F5){ref-type="fig"}) and milk retention ([Fig. 3](#F3){ref-type="fig"}) were in turn the most likely reasons behind delayed alveolar collapse in *Atg*-deficient mammary glands ([Fig. 3](#F3){ref-type="fig"}).

![**Figure 5.** Involution delay in *Atg*-deficient mammary glands is associated with dead cell accumulation in alveolar lumens. (**A**) Cleaved CASP3 IHC on mammary glands from wild-type and *Becn1^+/−^* mice on involution days 1 and 4. (**B**) Quantification of post-lactational apoptotic bodies in mammary glands from wild-type and *Becn1^+/−^* mice during involution days 0.5--21. (**C**) Fraction of apoptotic bodies engulfed by living MECs in mammary glands from wild-type (blue line) and *Becn1^+/−^* (red line) mice during involution days 1--5. (**D**) Cleaved CASP3 IHC on mammary glands from wild-type and MEC-specific *Atg7*-deficient mice on involution days 1 and 4. (**E**) Quantification of post-lactational apoptotic bodies in mammary glands from wild-type and MEC-specific *Atg7*-deficient mice during involution days 0.5--21. (**F**) Fraction of apoptotic bodies engulfed by living MECs in mammary glands from wild-type (green line) and MEC-specific *Atg7*-deficient (yellow line) mice during involution days 1--5. (**G**) Apoptotic body distribution between non-engulfed (i.e., in alveolar lumens, L) and engulfed (i.e., inside MECs in alveolar wall, W) fractions in mammary glands from wild-type (blue and green bars), *Becn1^+/−^* (red bars) and MEC-specific *Atg7*-deficient (yellow bars) mice during days 2--4 post-weaning. \*\*p 0.001, \*p 0.01.](auto-9-459-g5){#F5}

*Atg* defects compromise MEC phagocytic ability in vivo without impairing PS exposure or MFGE8 levels, but in association with decreased expression of apoptotic body receptors on phagocytes
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The in vivo phagocytic ability of wild-type and *Atg*-defective MECs during involution was quantified and a significantly decreased phagocytic index for *Becn1^+/−^* MECs was observed ([Fig. 6A](#F6){ref-type="fig"}). Phagocytic index quantification by EM was performed only for *Becn1^+/−^* glands, as in this model all MECs were *Becn1*-heterozygous, whereas in the ATG7 model, despite the well-documented and efficient transgene deletion in the secretory epithelial cells,[@R35]^,^[@R36] individual MECs scored for phagocytic ability could be wild type and might have negatively impacted the accuracy of phagocytic index determination.

![**Figure 6.***Atg*-deficiency impairs efferocytosis during mammary involution in association with decreased MERTK and ITGB5 levels, but without compromising PS exposure on apoptotic bodies or MFGE8 expression. (**A**) (Left panel) EM micrographs of *Becn1^+/+^* and *Becn1^+/−^* mammary glands on day 2 post-weaning. Red arrows point to autophagosomes (engulfed by MECs in wild type, non-engulfed in *Becn1^+/−^* gland); (Right panel) Phagocytic index, i.e., fraction of engulfed over total number of autophagosomes in HPF. (**B**) Annexin V IHC on mammary glands from wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice on day 2 post-weaning. (**C**) MFGE8 IHC on mammary glands from wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice on day 3 post-weaning. (**D**) MERTK, ITGB5, CD14 and CD68 IHC on mammary glands from parous wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice at 48 h post-weaning.](auto-9-459-g6){#F6}

To elucidate the mechanism underlying the dead cell clearance defect in *Atg*-deficient involuting mammary glands, we serially investigated the functionality of different efferocytosis players,[@R41] starting with the apoptotic cells, which are known to 'actively' participate in their own removal by exposing 'eat-me' receptors (PS) on their cell membranes, thus providing recognition signals to neighboring phagocytes. Wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient involuting mammary glands showed similar PS exposure on dead cells ([Fig. 6B](#F6){ref-type="fig"}), indicating that *Atg*-defective MECs give rise to "phagocytosis-competent" ABs in vivo.

Milk fat globule-EGF-factor 8 (MFGE8) is a glycoprotein at the apical plasma membrane of secretory MECs and on the milk fat globule membrane (MFGM) around secreted milk fat that acts as an opsonin and facilitates AB clearance; MFGE8 deficiency results in dead cell accumulation during involution,[@R42] similar to that described above for *Atg*-deficient mammary glands ([Fig. 5A, D and G](#F5){ref-type="fig"}). MFGE8 protein levels in wild-type and *Atg*-deficient mammary tissues were similar ([Fig. 6C](#F6){ref-type="fig"}), thus excluding altered MFGE8 expression as contributing to AB accumulation in *Atg*-defective mammary glands.

We next examined the expression of AB receptors on phagocytes, concentrating on those implicated in MEC-mediated efferocytosis,[@R10]^,^[@R27]^,^[@R43] and found that MERTK and integrin β5 (ITGB5) exhibited decreased levels in *Atg*-deficient mammary glands, whereas other receptors, such as CD14, which is upregulated during involution and becomes exposed on the surface of MECs in a STAT3-dependent manner,[@R10]^,^[@R19] and CD68 showed genotype-independent expression ([Fig. 6D](#F6){ref-type="fig"}).

Persistence of inflammation and ductal ectasia in *Atg*-defective mammary glands
--------------------------------------------------------------------------------

Defective dead cell clearance commonly results in inflammation, as secondary necrosis and highly immunogenic intracellular antigen exposure occur in parallel with decreased anti-inflammatory cytokine secretion by phagocytes.[@R44] To investigate whether dead cell accumulation in *Atg*-defective mammary glands altered the inflammatory response normally associated with involution,[@R27] macrophage infiltration was assessed ([Fig. 7A and B](#F7){ref-type="fig"}). In wild-type glands, macrophages were clearly present until involution day 10, but depleted in fully involuted glands, whereas in *Atg*-deficient mammary tissues, macrophages persisted past involution completion ([Fig. 7A and B](#F7){ref-type="fig"}), were of the alternatively activated M2 subtype[@R45] ([Fig. 7C](#F7){ref-type="fig"}, left column), and were accompanied by increased collagen deposition ([Fig. 7C](#F7){ref-type="fig"}, right column). *Atg*-deficient mammary glands from older multiparous mice demonstrated prominent ductal ectasia ([Fig. 7D](#F7){ref-type="fig"}), which---though not a preneoplastic condition itself---is indicative of abnormal ductal remodeling in association with defective dead cell clearance during mammary involution.

![**Figure 7.** Involution delay due to *Atg*-deficiency is accompanied by persistence of inflammation, M2-macrophage infiltration, increased collagen deposition and ductal ectasia. (**A**) F4/80 IHC on mammary glands from wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice on days 5--21 post-weaning. (**B**) Macrophage quantification in mammary glands from wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice on days 5--21 post-weaning. (**C**) ARG1 IHC (left column); Mason trichrome staining (right column) on mammary glands from wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice on day 21 post-weaning. (**D**) Whole gland mount (left column) and H&E-stained sections (right column) of mammary glands from parous wild-type, *Becn1^+/−^* and MEC-specific *Atg7*-deficient mice.](auto-9-459-g7){#F7}

ATG protein knockdown compromises iMMEC phagocytic ability in vitro in association with decreased apoptotic body engulfment and impaired Rac activation
-------------------------------------------------------------------------------------------------------------------------------------------------------

To further investigate the mechanism(s) underlying the in vivo efferocytosis defect of *Atg*-defective MECs, we initially used iMMEC cell lines derived from *Becn1^+/+^* and *Becn1^+/−^* mice.[@R39] To our surprise, *Becn1^+/−^* iMMECs, which are partially defective in autophagy induction under metabolic stress,[@R39] did not exhibit any significant phagocytosis impairment ([Fig. 8A](#F8){ref-type="fig"}). This result, though unexpected, has a precedent in earlier work,[@R46] where the PS exposure defect documented in *Becn1*- and *Atg5*-null ES cells in a 3D-model of embryoid body cavitation was not observed in single layer ES cell culture treated with apoptosis-inducing agents, thus indicating that in vivo properties of *Atg*-defective cells may be altered in regular 2D-culture.

![**Figure 8.** BECN1 or ATG7 knockdown in wild-type iMMECs compromises efferocytosis in vitro without affecting PS exposure on apoptotic bodies, but in association with decreased engulfment-related RAC1 activation. (**A**) Phagocytic index for stable *Becn1^+/−^* and *Becn1^+/−^* iMMEC lines in vitro. (**B**) Phagocytic index for wild-type iMMECs treated with scrambled or *Atg* (*Becn1* or Atg7) siRNA. (**C**) Quantification of BECN1 and ATG7 knockdown in wild-type iMMECs. (**D and E**) FACS-based quantification of PS exposure on apoptotic bodies derived from wild-type iMMECs treated with scrambled or *Atg* (*Becn1* or *Atg7*) siRNA. (**F**) Efferocytosis-induced RAC1 activation in wild-type iMMECs treated with scrambled or *Atg* (*Becn1* or *Atg7*) siRNA.](auto-9-459-g8){#F8}

In contrast, BECN1 or ATG7 knockdown (KD) by siRNA decreased the phagocytic index of wild-type iMMECs ([Fig. 8B and C](#F8){ref-type="fig"}). Furthermore, similar to the in vivo results ([Fig. 6B](#F6){ref-type="fig"}), BECN1 or ATG7 KD did not affect PS exposure on resultant ABs ([Fig. 8D and E](#F8){ref-type="fig"}). Given decreased MERTK and ITGB5 levels in *Atg*-defective mammary glands during involution in vivo ([Fig. 7E](#F7){ref-type="fig"}) and, thus, predicted impairment of their downstream effector RAC1, which mediates actin reorganization and phagocytic cup formation for effective dead cell engulfment,[@R47] we investigated whether BECN1 or ATG7 KD affected RAC1 activation during efferocytosis in vitro and found that in both cases RAC1 upregulation was significantly compromised ([Fig. 8F](#F8){ref-type="fig"}), again indicating that impaired efferocytosis due to *Atg* defects can be attributed, at least partially, to defective engulfment.

Discussion
==========

Using the *Gfp-Lc3* autophagy-reporter mouse model,[@R28] we found that autophagy is induced shortly after weaning and is accompanied by transcriptional upregulation of ATG proteins. Our findings are in agreement with earlier DNA microarray studies,[@R10]^,^[@R48] which included data on induction of ATG proteins and their regulators during early involution in parallel with downregulation of autophagy suppressors, such as AKT and MTOR. MEC apoptosis is maximal and autophagy status-independent during the first 72 h post-weaning ([Fig. 5B and E](#F5){ref-type="fig"}). In wild-type mammary glands, apoptotic cell number drops acutely by involution day 4 and nears zero by day 5, suggesting that most dead cells are efficiently cleared between 72 and 96 h, i.e., after the peak in autophagosome formation and prior to significant macrophage infiltration from external sites.[@R8] In contrast, in *Becn1^+/−^* or MEC-specific *Atg7*-deficient mammary glands, dead cells abnormally accumulated at involution days 4 and 5, indicating that *Atg*-deficient mammary tissues exhibited defective efferocytosis. It is of great interest that a recent study demonstrates the essential role of macrophages during the first phase of involution;[@R49] our results complement this study, as well as earlier work,[@R8]^,^[@R43] in showing that both MECs and macrophages have critical contributions to proper execution of this important developmental process.

Accelerated apoptosis cannot be ruled out as a reason behind dead cell accumulation in *Atg*-defective glands; however, the finding that *Becn1^+/−^* and *Atg7*-deficient MECs exhibit decreased dead cell engulfment even at 48 and 72 h post-weaning ([Fig. 5C and F](#F5){ref-type="fig"}), when the total number of ABs is *Atg*-independent ([Fig. 5B and E](#F5){ref-type="fig"}), clearly indicates a defect in dead cell clearance in *Atg*-deficient mammary glands.

An earlier study reports that *Atg* defects result in cell corpse persistence due to failed AB clearance during embryonic cavitation.[@R46] In that case, dying cells in *Atg5*- or *Becn1*-null embryoid bodies (EBs) fail to generate energy-dependent engulfment signals, such as the 'eat-me' (PS exposure) and the 'come-get-me' (LPC secretion) signals, and the efferocytosis defect is attributed to the production of 'defective' ABs by *Atg*-defective cells. However, in the afore-mentioned study, other mechanisms potentially impairing AB clearance were not investigated, leaving open the possibility of defects in other dead cell clearance effectors, such as phagocytes.

Our results demonstrate proper PS exposure on *Atg*-deficient ABs in vivo ([Fig. 6B](#F6){ref-type="fig"}) and in vitro ([Fig. 8B](#F8){ref-type="fig"}) and, together with *Atg*-independent expression of the opsonin MFGE8 ([Fig. 6C and D](#F6){ref-type="fig"}), indicate that defective phagocytes account for the efferocytosis impairment. This finding is in close agreement with studies on dead cell[@R34] and pathogen[@R29] phagocytosis by macrophages, apoptotic corpse clearance during *C. elegans* development,[@R32]^,^[@R33] and the live-cell-engulfment process of entosis.[@R32] The novel contribution of our work is in reporting for the first time that *Atg* defects in MECs impair efferocytosis during mammary involution in vivo at the early step of engulfment. Our results are greatly supported by a completely independent study that has recently reported involvement of BECN1 in engulfment of apoptotic cells by macrophages and fibroblasts in vitro.[@R50] Thus, inefficient efferocytosis---and by extension, phagocytosis---likely involves more aspects of the phagocytic process than the previously documented endocytic processing. Although we did not investigate processing in *Atg*-deficient MECs, it is quite likely defective, given the emerging literature mentioned above. The combination of engulfment and processing defects in *Atg*-deficient MECs is very intriguing, especially in light of recent work indicating that engulfment depends on apoptotic material processing.[@R51] In support of this hypothesis, we never detected *Becn1^+/−^* MECs "stuffed" with ABs; instead in all cases examined, multiple apoptotic corpses were near or on the phagocyte, but only one was ingested, as if engulfment rate were strictly regulated. Whether the engulfment defect in *Atg*-deficient MECs is primary or secondary to a feedback loop controlled by endocytic processing will be the subject of future studies. Elucidation of the nature of the engulfment defect in *Atg*-deficient MECs and its etiologic connection to decreased MERTK and ITGB5 expression will also be investigated.

Autophagy protein defects delay mammary involution
--------------------------------------------------

Autophagy induction was previously documented in involuting bovine mammary glands,[@R52] but our studies are the first to demonstrate the functional role of ATG proteins in mammary involution using transgenic mouse models. Participation of the autophagic machinery in involution process is not surprising given accumulating evidence for the critical role of autophagy in diverse developmental events,[@R53] such as spore formation in yeast,[@R54]^,^[@R55] dauer formation in *C. elegans*,[@R56] oocyte-to-embryo[@R57] and embryo-to-neonate[@R58]^-^[@R61] transitions in mammals. Autophagy induction during developmental tissue remodeling often accompanies apoptosis, as exemplified by germline P granule degradation in somatic cells in *C. elegans*[@R62]^,^[@R63] and by salivary gland[@R63] and midgut[@R64] degradation in Drosophila; furthermore, autophagy is essential for midgut cell death even when apoptosis is inhibited.[@R64] The latter studies implicate autophagy as an active PCD mechanism in Drosophila, which is a an intriguing finding given the more commonly observed cytoprotective roles of autophagy.[@R65] In our studies, autophagy and apoptosis are induced in parallel during mammary involution and whole organ or MEC-specific *Atg* defects transiently delay mammary gland remodeling due to impaired dead cell clearance after the peak of autophagosome formation and without affecting apoptotic rates. Thus, although autophagy as a process of self-eating is not essential for MEC death, ATG proteins are required for AB clearance and, thus, act as late PCD and heterophagy effectors.[@R66] In this respect, our studies shed light into the function of ATG proteins as mediators of efferocytosis which, though related to and sharing machinery with, is a process distinct from autophagy, as it does not involve self-cannibalism. Quite interestingly, whole mounts of *Atg*-deficient involuting mammary glands ([Fig. 4](#F4){ref-type="fig"}) show persistent mammary tissue compared with wild-type glands, macroscopically reminiscent of the developmentally nondegraded *atg*-mutant Drosophila salivary glands.[@R63] Given the more recently reported requirement for the engulfment receptor Draper in activation of autophagy regulators and degradation of Drosophila salivary glands[@R67] and our results of impaired efferocytosis in *Atg*-deficient mammary glands in association with decreased MERTK and ITGB5 expression, it is conceivable that Drosophila salivary gland degradation and mammary involution may be very similar in their utilization of ATG proteins for efficient cell clearance during development. Further investigation will provide critical insight into the similarities and differences between these two developmentally important PCD processes.

Mammary epithelial cells as nonprofessional phagocytes
------------------------------------------------------

In the mammary gland, epithelial cell death followed by corpse clearance is a frequent event, first observed in puberty, when solid epithelial cords are canalized to form ductal outgrowths,[@R68] and then recurring through the entire female reproductive life with each menstrual/estrous cycle, during which the mammary epithelium proliferates moderately and either continues to do so if pregnancy occurs or undergoes apoptosis.[@R69] The most extreme form of this cell proliferation-followed-by-cell death process happens during pregnancy, lactation and subsequent involution, at which time AB clearance is essential for proper stroma remodeling and mammary gland regression to a "quiescent" state.[@R1] It is of great interest that the cells responsible for dead body removal are living MECs acting as nonprofessional phagocytes.[@R8]^,^[@R27] Recent work using mice deficient for different receptor tyrosine kinases that regulate efferocytosis in macrophages showed that MERTK, but not AXL or TYRO3, is critical for MEC-mediated efferocytosis in the postpartum mammary gland,[@R43] a finding that is in agreement with our observation that MERTK and ITGB5 expression was suppressed in *Atg*-deficient involuting mammary glands. Indeed the *Mertk*-null mice exhibited the same post-lactational involution phenotype as our *Atg*-deficient models: AB accumulation and stagnant milk in alveolar lumens by involution day 3, followed by eventual dead cell and debri clearance in association with epithelial and stromal alterations. In the MERTK and BECN1 models, both MECs and macrophages were *mertk^−/−^* and *Becn1^+/−^*, respectively, raising the possibility that defective professional phagocytes were at least partially responsible for impaired efferocytosis. Transplantation of *mertk^−/−^* mammary epithelium into wild-type mammary fat pads resulted in a similar dead-cell-accumulation phenotype, suggesting that MECs are the primary efferocytes during involution. Our ATG7 mammary model combines phagocytosis-defective (*atg7^−/−^*) MECs and wild-type stroma in the same transgenic mouse for the first time and, thus, proves beyond a doubt that MECs are the primary efferocytes during involution.

Involution-associated inflammation
----------------------------------

Transient inflammation is an undisputable characteristic of mammary involution, as macrophages infiltrate the mammary gland by day 4 post-weaning and orchestrate stroma remodeling. Increased immune mediator expression during involution is consistent with an immune cascade resembling an early acute-phase response and a wound healing process.[@R10]^,^[@R15]^,^[@R48] In breast cancer, macrophage infiltration and PABC are both associated with poor clinical outcomes, an observation that led to the involution-hypothesis stating that the wound healing microenvironment of the involuting mammary gland is tumor-promotional and implicated in the high rate of associated distant metastasis.[@R11]^,^[@R12] Examination of rodent and human mammary tissues revealed that involution macrophages and their associated stroma exhibit characteristics possibly driving breast cancer progression, such as an alternatively activated M2 phenotype, IL4 and IL13 proinflammatory cytokine production, fibrillar collagen accumulation and high cyclooxygenase 2 (PTGS2) expression.[@R45]^,^[@R70] Our studies revealed that ineffective AB clearance due to *Atg* deficiencies result in inflammation that persists beyond full mammary gland regression ([Fig. 7A--C](#F7){ref-type="fig"}), indicating that ATG protein defects may alter the tumor-modulating properties of the mammary microenvironment during involution and, thus, affect tumor progression risk. *Atg*-deficient mammary glands from retired breeders exhibit ductal ectasia, which, although not considered a preneoplastic change, is a manifestation of abnormal mammary gland remodeling. At this point, the etiologic origin of the ductal ectasia phenotype cannot be precisely defined, as more than one process can be contributing to it, including the intraductal persistence of ABs and its resultant proinflammatory response and/or the chronic inflammation due to defective autophagy-induced cell susceptibility to metabolic and tissue stressors. Along the same lines, not only inflammation may follow decreased AB clearance, but also defective autophagy-associated inflammation may impair the phagocytic ability of MECs, leading to a self-sustaining proinflammatory microenvironment. Whether impaired efferocytosis and persistent inflammation due to *Atg* deficiencies are mechanistically connected to lower BECN1 expression in human breast cancer[@R71] remains to be investigated.

Materials and Methods
=====================

Mice and induction of involution
--------------------------------

*Becn1^+/−^*,[@R72]*Atg7*^F/F^;WAP-*Cre*[@R73] and *Gfp-Lc3*[@R74] mice were previously described.

PCR primers for genotyping were as following:

Becn1:

NeoESPCR2: 5′- CGC CTT CTA TCG CCT TCT TGA CG-3′

BCNKOT-1C: 5′-TGG AGG GCA GTC CAT ACC CTG-3′

BCNKOT-2R: 5′-GAG CTG GCT CCT GTG AGT ATG-3′

*Atg7*^F^:

Hind-Fw: 5′-TGG CTG CTA CTT CTG CAA TGA TGT-3′

Pst-Rv: 5′-CAG GAC AGA GAC CAT CAG CTC CAC-3′

Cre:

C001: 5′-ACC AGC CAG CTA TCA ACT CG-3′

C002: 5′-TTA CAT TGG TCC AGC CAC C-3′

Gfp-Lc3:

GFP(LC3)1: 5′-TCC TGC TGG AGT TCG TGA CCG-3′

LC3\*rc3: 5′-TTG CGA ATT CTC AGC CGT CTT CAT CTC TCT CGC-3′

Mice were housed in a pathogen-free facility at the Child Health Institute of New Jersey. Animal protocols were IACUC-approved. *Atg7*^F/F^;WAP-*Cre* mice were used after two pregnancy-lactation cycles to ensure maximum CRE-recombination.[@R35]^,^[@R36] For involution studies, litter size was normalized to 6--8 pups. After 14 d of nursing,[@R8]^,^[@R42]^,^[@R45] dams were separated from their pups. Thoracic and abdominal mammary glands were harvested at 0--21 d time points after forced weaning, 3--5 mice per time point. Mammary glands were also harvested from nulliparous and multiparous mice at older ages.

qRT-PCR
-------

Protein and RNA were isolated from nulliparous, lactating and involuting *Becn1^+/−^* and MEC-specific *Atg7*-deficient mammary glands using the PARIS kit (Applied Biosystems). Brilliant II SYBR Green 2-step QRT-PCR with AffinityScript Master Mix (Agilent) was used to convert 100 ng RNA to cDNA using a Veriti Thermal Cycler (Applied Biosystems). Relative mRNA expression was analyzed on a Stratagene MX3005P (Agilent), normalized to a housekeeping gene (*Acta1*) and compared with mRNA from virgin mammary glands using the ΔΔCt method performed by the Comparative module on the MxPro software (Agilent).

Primers (Integrated DNA Technologies) used were as following: *Acta1* Forward: 5′-GGTATCGCT GACCGCATGCAGA-3′, Reverse: 5′-CCTGAG GAGAGAGAGCGCGAACG-3′; *Becn1* Forward: 5′-CTCAAGTGGGGTCTTGCCTGGG T-3′ Reverse: 5′-GAAAGGATGCATGGGGCT GAGTC-3′; *Map1lc3α* Forward: 5′-TAATCAGACGG CGCTTGCAGCT-3′ Reverse: 5′-TGTGGGTGG TGAGCCGTCCA-3′

Cell culture
------------

*Becn1^+/+^* and *Becn1^+/−^* mouse mammary epithelial cells (MMECs) were isolated and immortalized (iMMECs) as previously described.[@R39] Wild-type iMMECs were electroporated with scrambled, *Becn1* or *Atg7* mouse siRNAs (Thermo Scientific, D-001050-01-20; M-055895-01-0005; M-049953-02-0020) for ATG regulator knockdown in vitro.

Cells were seeded on 100-mm plastic dishes, 6-well plates, coverslips or chamber slides depending on specific experiment and grown in F12 medium supplemented with 10% FBS, 5 μg/ml insulin, 1 μg/ml hydrocortisone, 5 ng/ml EGF, 100 U/ml penicillin and streptomycin at 37°C in a humidified atmosphere containing 5% CO~2~. To induce apoptosis, cells were incubated in glucose/serum-free Dulbecco's modified Eagle's medium (DMEM) supplemented with hormones and antibiotics for 14 h.

Mammary gland processing and analysis
-------------------------------------

Whole mount: Freshly dissected abdominal mammary glands were spread between glass slides and fixed in 4% paraformaldehyde (PFA) at room temperature (RT) for 2 h. After acetone defatting and alcohol rehydration, tissues were stained overnight in carmine alum solution (Carmine, Sigma C-1022; aluminum potassium sulfate, Sigma A-7167) followed by dehydration and clearing in xylene.

For H&E and IHC, glands were fixed in 4% PFA, embedded in paraffin and sectioned. H&E staining followed by digital scanning was performed at the Mouse Pathology Laboratory, University of California, Davis.

For frozen sections, tissues were incubated in sucrose gradient prior to processing. Sections were fixed in acetone and mounted with ProLong Gold antifade reagent (Invitrogen, P36930). EGFP-LC3 fluorescence was monitored by epifluorescence microscopy.

For IHC, sections were deparaffinized in xylene, rehydrated with alcohol and blocked with 3% peroxide, followed by 1 h incubation with 5% goat serum or 5% BSA, depending on primary antibody source. Vector M.O.M. Immunodetection kit (Vector Laboratories, BMK-2202) was used for rat primary antibody.

Tissue sections were incubated at RT for 1 h or at 4°C overnight with the following primary antibodies: rabbit polyclonal anti-ATG7 (Sigma, A2856), rabbit polyclonal anti-BECN1 (Santa Cruz, sc-11427), rabbit polyclonal anti-LC3 (Novus, NB100-2331), rabbit polyclonal anti-cleaved caspase-3 (Cell Signaling, 9661), rat monoclonal anti-F4/80 (AbD Serotec, A3-1, MCA497), rabbit polyclonal anti-iNOS/NOS Type II (BD Transduction Laboratories, 610333), goat polyclonal anti-Arginase-1 (Santa Cruz, sc-18351), rabbit polyclonal anti-MERTK (FabGenuix, MKT-121AP), rabbit polyclonal anti-ITGB5 (Santa Cruz, sc-14010), rabbit polyclonal anti-CD14 (Abcam, ab106285), rat monoclonal anti-CD68 (AbD Serotec, FA-11, MCA-1957GA), rabbit monoclonal anti-MFGE8 (kindly provided by Dr. Kamran Atabai, University of California, San Francisco). Sections were further incubated at RT for 1 h with the following biotinylated antibodies: goat polyclonal anti-rabbit (Novus, NB 730-B) or bovine anti-goat (Jackson ImmunoResearch, 711-065-152). Antibodies were diluted in 5% goat serum, 5% BSA or M.O.M. diluent, depending on specific antibody source. Vectastain Elite ABC Reagent (Vector Laboratories, PK-7100) and DAB+ Substrate Chromogen Kit (Dako, K3468) were used to visualize biotin signal.

For collagen staining, deparaffinized and rehydrated sections were incubated overnight at RT in Bouin's solution (Sigma, HT10132-1L) prior to Masson trichrome staining (Sigma Accustain Trichrome Kit HT15).

For phosphatidylserine (PS) detection in vivo, glands were incubated in Annexin-V-Biotin in Ca-binding buffer (TACS Annexin V-Biotin kit, Trevigen 4835-01-K) according to the manufacturer's instructions prior to fixation with 4% PFA, paraffin-embedding and sectioning. Dewaxed and rehydrated sections were incubated with 3% peroxide, rinsed and blocked with 5% goat serum, incubated at 4°C overnight with Vectastain Elite ABC Reagent, rinsed with 0.5% Tween-20 in PBS and developed in DAB+ Substrate.

For all staining described above, sections were mounted with Permount medium (Fisher, SP15-100).

Electron microscopy
-------------------

1-mm^3^ specimens were excised from 3 randomly selected areas of abdominal mammary glands, fixed in 2.5% glutaraldehyde, 4% PFA, 8 mM CaCl~2~ in 0.1 M cacodylate buffer pH 7.4, and processed for conventional electron microscopy at UMDNJ Electron Microscopy Core facility (JEOL 1200EX electron microscope).

Phosphatidylserine analysis in vitro
------------------------------------

Wild-type iMMECS transfected with scrambled, *Becn1* or *Atg7* siRNAs were grown in 6-well plates in regular growth medium for 48 h, then in serum/glucose-free DMEM to initiate apoptosis. Apoptotic cells were harvested 14 h later and stained (unfixed) with FACS Annexin V-FITC kit (Trevigen, 4830-01-K). FITC /PI cell ratio was determined within 1 h using Beckman-Coulter Cytomics FC500 Flow Cytometer. To visualize PS exposure, cells were grown on coverslips, starved overnight, stained with Annexin V-FITC/PI, and mounted with ProLong Gold antifade medium.

Macrophage quantification
-------------------------

Macrophage infiltration was quantified by using the measurement option of the ProgRes CapturePro 2.5 camera software. Basically, F4/80-stained areas for macrophages and hematoxylin-stained areas for mammary tissues were measured on paraffin-embedded specimen sections (images taken at 400x magnification). Ten fields/section and one section from 3 different mice per genotype per involution time point were analyzed. Results are presented as macrophage (F4/80 staining) to tissue (hematoxylin staining) ratios.

Phagocytosis assays
-------------------

FACS-based assay: iMMECs transfected with scrambled, *Becn1* or *Atg7* siRNA recovered for 48 h post-transfection. Wild-type iMMECs labeled with red fluorescent cell linker PKH26 (Sigma, MINI26) were maintained in glucose/serum-free DMEM for 36 h for apoptosis induction. Cell death was verified by Annexin V-FITC/PI staining. PKH26-labeled apoptotic cells were added in 1:10 ratio to siRNA-transfected cells growing in regular growth medium and co-cultured for 14 h. Phagocyte monolayer was washed with PBS to remove bound, nonengulfed, apoptotic cells, stained with CellTracker Green BODIPY dye (Invitrogen, C2102), harvested by trypsinization and fixed with 1% PFA for 20 min on ice. Samples were acquired on an Amnis Imagestream 100 and analyzed by IDEAS 4.0 software. Internalization was determined by first gating for nuclear stain (Draq5) to identify intact cells. These were then analyzed for BODIPY Green-positive cells (phagocytes) by gating for Intensity BODIPY Green. Single cells were selected to remove large aggregates and doublets and then analyzed for percent PKH26-positive cells by gating for Intensity PKH26 vs. Area Draq5 to exclude conjugates and aggregates. PKH26-positive events were gated off of BODIPY Green cells alone as a control.

RAC1 activation assay
---------------------

Cells were grown and siRNA transfections were performed as described above. Wild-type apoptotic cells were added in 1:10 ratio; phagocytosis was terminated by ice-cold PBS wash. Phagocyte monolayer was washed with PBS to remove bound, nonengulfed apoptotic cells and harvested by scraping at 0, 0.5 and 5 h time points after apoptotic cell addition. Assay was performed with G-LISA RAC Activation Assay Biochem (absorbance-based kit, Cytoskeleton BK125) according to manufacturer's manual, except that cells were grown in serum-containing medium to avoid starvation-induced effect on autophagy status. Coverslips were stained for actin with Rhodamine Phalloidin (Cytoskeleton, PHDR1).

Statistical analysis
--------------------

Student's t-test was used for statistical analysis.
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AB

:   apoptotic body

AKT

:   v-akt murine thymoma viral oncogene homolog/PKB

ATG

:   autophagy-related

ARG1

:   arginase 1

AXL

:   AXL receptor tyrosine kinase

BECN1

:   Beclin 1

BSA

:   bovine serum albumin

CaCl~2~

:   calcium chloride

CASP3

:   caspase 3

CD

:   cluster of differentiation

DAB

:   3, 3′-diaminobenzidine

DAPI

:   4',6-diamidino-2-phenylindole

DMEM

:   Dulbecco's modified Eagle\'s medium

EGF

:   epidermal growth factor

EM

:   electron microscopy

ES

:   embryonic stem

FACS

:   fluorescence-activated cell sorting

FBS

:   fetal bovine serum

FITC

:   fluorescein isothiocyanate

GFP

:   green fluorescent protein

H&E

:   hematoxylin and eosin

HPF

:   high power field

IGFBP

:   insulin growth factor-binding protein

IHC

:   immunohistochemistry

IL

:   interleukin

iMMEC

:   immortalized mouse mammary epithelial cell

iNOS

:   inducible nitric oxide synthase

I (Inv)

:   involution

ITGB5

:   integrin beta 5

JAK

:   janus kinase

L (Lact)

:   lactation

LC3

:   microtubule-associated protein 1 light chain 3

LIF

:   leukemia inhibitory factor

LPC

:   lysophosphatidylcholine

MEC

:   mammary epithelial cell

MERTK

:   c-mer proto-oncogene tyrosine kinase

MFGE8

:   milk fat globule-EGF-factor 8

MFGM

:   milk fat globule membrane

MMP

:   matrix metalloproteinase

M.O.M.

:   mouse on mouse

MTOR

:   mechanistic target of rapamycin

RAC1

:   ras-related C3 botulinum toxin substrate 1

PABC

:   pregnancy-associated breast cancer

PCD

:   programmed cell death

PFA

:   paraformaldehyde

PI

:   propidium iodide

PS

:   phosphatidylserine

PTGS2

:   prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)

qRT-PCR

:   quantitative reverse transcriptase polymerase chain reaction

RT

:   room temperature

SQSTM1

:   sequestosome-1/p62

STAT3

:   signal transducer and activator of transcription 3

TGFB

:   transforming growth factor beta

TGFBR2

:   transforming growth factor beta receptor 2

TYRO3

:   TYRO3 protein tyrosine kinase

WAP

:   whey acidic protein
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